{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:24:31Z","timestamp":1791854671772,"version":"4.3.4"},"reference-count":35,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2013,4,25]],"date-time":"2013-04-25T00:00:00Z","timestamp":1366848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Addict"],"published-print":{"date-parts":[[2013,5]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Recent policy initiatives in Baltimore City, MD significantly reduced access disparities between methadone and buprenorphine in the publicly funded treatment sector.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study examines reasons for choosing buprenorphine over methadone among patients with access to both medications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>This study was embedded within a larger clinical trial conducted at two outpatient substance abuse treatment programs offering buprenorphine. Qualitative and quantitative data on treatment choice were collected for new patients starting buprenorphine treatment (n\u2009=\u200980). The sample consisted of predominantly urban African American (94%) heroin users who had prior experience with non\u2010prescribed street buprenorphine (85%), and opioid agonist treatment (68%). Qualitative data were transcribed and coded for themes, while quantitative data were analyzed using descriptive and bivariate statistics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Participants typically conveyed their choice of buprenorphine treatment as a decision against methadone. Buprenorphine was perceived as a helpful medication while methadone was perceived as a harmful narcotic with multiple unwanted physical effects. Positive experiences with non\u2010prescribed \u201cstreet buprenorphine\u201d were a central factor in participants' decisions to seek buprenorphine treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Differences in service structure between methadone and buprenorphine did not strongly influence treatment\u2010seeking decisions in this sample. Personal experiences with medications and the street narrative surrounding them play an important role in treatment selection decisions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Scientific Significance<\/jats:title><jats:p>This study characterizes important decision factors that underlie patients' selection of buprenorphine over methadone treatment. (Am J Addict 2013; 22:285\u2013291)<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1521-0391.2012.12004.x","type":"journal-article","created":{"date-parts":[[2013,4,25]],"date-time":"2013-04-25T15:55:23Z","timestamp":1366905323000},"page":"285-291","source":"Crossref","is-referenced-by-count":74,"title":["Patient Perspectives on Choosing Buprenorphine Over Methadone in an Urban, Equal\u2010Access System"],"prefix":"10.1111","volume":"22","author":[{"given":"Jan","family":"Gryczynski","sequence":"first","affiliation":[{"name":"Friends Research Institute Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome H.","family":"Jaffe","sequence":"additional","affiliation":[{"name":"Friends Research Institute Baltimore, Maryland"},{"name":"University of Maryland School of Medicine Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Friends Research Institute Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi A.","family":"Du\u0161ek","sequence":"additional","affiliation":[{"name":"Friends Research Institute Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishan","family":"Gugsa","sequence":"additional","affiliation":[{"name":"Friends Research Institute Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristin L.","family":"Monroe","sequence":"additional","affiliation":[{"name":"Friends Research Institute Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"O'Grady","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Maryland College Park, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yngvild K.","family":"Olsen","sequence":"additional","affiliation":[{"name":"Institutes for Behavior Resources Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon Gwin","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Friends Research Institute Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,4,25]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2005.02.007"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.22.1936"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00055-3"},{"key":"e_1_2_5_5_1","first-page":"49","article-title":"Failure of physicians to prescribe pharmacotherapies for addiction: Regulatory restrictions and physician resistance","volume":"13","author":"Weber EM.","year":"2010","journal-title":"J Health Care Law Policy."},{"key":"e_1_2_5_6_1","volume-title":"The SAMHSA Evaluation of the Impact of the DATA Waiver Program. Summary Report","author":"Stanton A.","year":"2006"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2006.03.013"},{"key":"e_1_2_5_8_1","unstructured":"Agency for Healthcare Research and Quality.Community partnerships and provider training increase service capacity and access to long\u2010term treatment for individuals with heroin addiction. AHRQ Healthcare Innovations Exchange. Available at:http:\/\/www.innovations.ahrq.gov\/content.aspx?id=1827. Accessed November 28 2011."},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.1.102"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990902968577"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.09.009"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2008.07.004"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550490802268835"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2011.06.005"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2009.10399907"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550490903077820"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2011.587392"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2009.10400539"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990701653826"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2010.10.016"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(92)90062-S"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.132.6.623"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1975.01760200078007"},{"key":"e_1_2_5_24_1","volume-title":"Qualitative Data Analysis","author":"Miles MB","year":"1994"},{"key":"e_1_2_5_25_1","first-page":"347","article-title":"Methadone maintenance treatment (MMT): A review of historical and clinical issues","volume":"67","author":"Joseph H","year":"2000","journal-title":"Mt Sinai J Med."},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826088509047261"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.17730\/humo.43.4.64m061v484th3871"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1081\/JA-120002807"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1991.10472571"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/79.4.571"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1992.10471646"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0b013e3181cc9610"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2010.07.009"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.07.019"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550880903014767"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2010.03.014"}],"container-title":["The American Journal on Addictions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1521-0391.2012.12004.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1521-0391.2012.12004.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T08:43:48Z","timestamp":1698655428000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1521-0391.2012.12004.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,25]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.1111\/j.1521-0391.2012.12004.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1521-0391.2012.12004.x","archive":["Portico"],"relation":{},"ISSN":["1055-0496","1521-0391"],"issn-type":[{"value":"1055-0496","type":"print"},{"value":"1521-0391","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,25]]}}}